Amlitelimab

DB18835InvestigationalProtein Based Therapies

Amlitelimab is under investigation in clinical trial NCT06181435 (A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older...

Mechanism: Pharmacologically active on Tumor necrosis factor ligand superfamily member 4
Curator reviewed
Code names: KY-1005 · KY-1005-2D10 · SAR445229

Resolves to

Compound

UNIIYZ6BH6TN8PCAS2378692-15-8

Targets

P23510TNFSF4

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Amlitelimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account